|
US5668255A
(en)
|
1984-06-07 |
1997-09-16 |
Seragen, Inc. |
Hybrid molecules having translocation region and cell-binding region
|
|
WO1994012629A1
(en)
|
1992-12-02 |
1994-06-09 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
DE69435108D1
(de)
|
1993-07-13 |
2008-08-14 |
Centelion |
Defekte adenovirus-vektoren und deren verwendung in der gentherapie
|
|
EP1012236A1
(en)
|
1997-08-15 |
2000-06-28 |
Rubicon Laboratory Inc. |
Retrovirus and viral vectors
|
|
US6399383B1
(en)
|
1997-10-28 |
2002-06-04 |
Maxygen, Inc. |
Human papilloma virus vectors
|
|
WO1999047691A1
(en)
|
1998-03-20 |
1999-09-23 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
ES2323744T3
(es)
|
1998-10-01 |
2009-07-23 |
University Of Southern California |
Sistema retroviral de suministro de genes y metodos de uso.
|
|
US6156514A
(en)
|
1998-12-03 |
2000-12-05 |
Sunol Molecular Corporation |
Methods for making recombinant cells
|
|
US6410013B1
(en)
|
1999-01-25 |
2002-06-25 |
Musc Foundation For Research Development |
Viral vectors for use in monitoring HIV drug resistance
|
|
WO2000072886A1
(en)
|
1999-05-26 |
2000-12-07 |
Dana-Farber Cancer Institute, Inc. |
Episomally replicating lentiviral vectors
|
|
AU2001257611A1
(en)
|
2000-04-28 |
2001-11-12 |
Avigen, Inc. |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
AU2001261515A1
(en)
|
2000-05-12 |
2001-11-26 |
The Regents Of The University Of California |
Treatment of human papillomavirus (hpv)-infected cells
|
|
AU2001265187A1
(en)
|
2000-05-30 |
2001-12-11 |
Baylor College Of Medicine |
Chimeric viral vectors for gene therapy
|
|
NO314588B1
(no)
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
|
|
US7122181B2
(en)
|
2000-12-19 |
2006-10-17 |
Research Development Foundation |
Lentiviral vector-mediated gene transfer and uses thereof
|
|
US20030138444A1
(en)
|
2001-08-18 |
2003-07-24 |
Myriad Genetics, Incorporated |
Composition and method for treating HIV infection
|
|
US20030119770A1
(en)
|
2001-08-02 |
2003-06-26 |
Zhennan Lai |
Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors
|
|
US7737124B2
(en)
|
2001-09-13 |
2010-06-15 |
California Institute Of Technology |
Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
|
|
US20070203333A1
(en)
|
2001-11-30 |
2007-08-30 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
|
WO2003079757A2
(en)
|
2002-03-20 |
2003-10-02 |
Massachusetts Institute Of Technology |
Hiv therapeutic
|
|
AU2003237159A1
(en)
|
2002-04-30 |
2003-11-17 |
University Of Florida |
Treatment for phenylketonuria
|
|
US20040161412A1
(en)
|
2002-08-22 |
2004-08-19 |
The Cleveland Clinic Foundation |
Cell-based VEGF delivery
|
|
CA2497552C
(en)
|
2002-09-06 |
2014-05-27 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
|
|
CA2504915A1
(en)
|
2002-11-04 |
2004-05-21 |
University Of Massachusetts |
Allele-specific rna interference
|
|
AU2003283174A1
(en)
|
2002-12-11 |
2004-06-30 |
Cytos Biotechnology Ag |
Method for protein production
|
|
US20040224402A1
(en)
|
2003-05-08 |
2004-11-11 |
Xcyte Therapies, Inc. |
Generation and isolation of antigen-specific T cells
|
|
EP1627231A2
(en)
|
2003-05-23 |
2006-02-22 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Improvements to gamma delta t cell-mediated therapy
|
|
EP1644508A1
(en)
|
2003-07-11 |
2006-04-12 |
Cytos Biotechnology AG |
Gene expression system
|
|
US20050019927A1
(en)
|
2003-07-13 |
2005-01-27 |
Markus Hildinger |
DECREASING GENE EXPRESSION IN A MAMMALIAN SUBJECT IN VIVO VIA AAV-MEDIATED RNAi EXPRESSION CASSETTE TRANSFER
|
|
US20050138677A1
(en)
|
2003-09-16 |
2005-06-23 |
Pfister Herbert J. |
Transgenic animal model for the treatment of skin tumors
|
|
EP1678292A4
(en)
|
2003-09-18 |
2008-05-07 |
Univ Emory |
IMPROVED MVA VACCINES
|
|
WO2005033282A2
(en)
|
2003-10-01 |
2005-04-14 |
Pharmacia & Upjohn Company Llc |
Polyamide compositions and therapeutic methods for treatment of human papilloma virus
|
|
US20080039413A1
(en)
|
2003-10-21 |
2008-02-14 |
Morris David W |
Novel compositions and methods in cancer
|
|
JPWO2005051927A1
(ja)
|
2003-11-26 |
2007-12-06 |
株式会社クレハ |
Ｈｉｖ−１感染末梢血単核球の刺激培養によるｃｄ４陽性ｔ細胞の培養方法、及びｈｉｖ−１の増殖阻害剤
|
|
WO2005081911A2
(en)
|
2004-02-25 |
2005-09-09 |
Dana-Farber Cancer Institute, Inc. |
METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION USING TRIM5α
|
|
US20060058255A1
(en)
|
2004-03-01 |
2006-03-16 |
Jianzhu Chen |
RNAi-based therapeutics for allergic rhinitis and asthma
|
|
TW201705980A
(zh)
|
2004-04-09 |
2017-02-16 |
艾伯維生物技術有限責任公司 |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
WO2005118802A2
(en)
|
2004-06-03 |
2005-12-15 |
The Regents Of The University Of California |
Targeting pseudotyped retroviral vectors
|
|
US20080131940A1
(en)
|
2004-06-25 |
2008-06-05 |
Robert Chiu |
Target Cell-Specific Short Interfering Rna and Methods of Use Thereof
|
|
EP1789447B1
(en)
|
2004-08-16 |
2012-04-25 |
Immune Disease Institute, Inc. |
Method of delivering rna interference and uses thereof
|
|
WO2006039721A2
(en)
|
2004-10-08 |
2006-04-13 |
The Board Of Trustees Of The University Of Illinois |
Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
|
|
EP1647595A1
(en)
|
2004-10-15 |
2006-04-19 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Nucleic acids against viruses, in particular HIV
|
|
CA2585523A1
(en)
|
2004-11-02 |
2006-05-11 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Adenoviral amplicon and producer cells for the production of replication-defective adenoviral vectors, methods of preparation and use thereof
|
|
US7790446B2
(en)
|
2005-02-11 |
2010-09-07 |
Kosagen Cell Factory Oü |
Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
|
|
CN101160055A
(zh)
|
2005-02-16 |
2008-04-09 |
莱蒂恩公司 |
慢病毒载体及其用途
|
|
WO2006089001A2
(en)
|
2005-02-16 |
2006-08-24 |
Lentigen Corporation |
Lentiviral vectors and their use
|
|
CA2609142C
(en)
|
2005-05-27 |
2016-02-09 |
Fondazione Centro San Raffaele Del Monte Tabor |
Therapeutic gene vectors comprising mirna target sequences
|
|
WO2007015122A1
(en)
|
2005-08-02 |
2007-02-08 |
Genexel, Inc. |
Therapy for alzheimer’s disease
|
|
US20070032443A1
(en)
|
2005-08-02 |
2007-02-08 |
Jaeseob Kim |
Therapy for Alzheimer's disease
|
|
WO2007056388A2
(en)
|
2005-11-07 |
2007-05-18 |
The General Hospital Corporation |
Compositions and methods for modulating poly (adp-ribose) polymerase activity
|
|
WO2007133674A2
(en)
|
2006-05-12 |
2007-11-22 |
Lentigen Corporation |
Lentiviral vector compositions, methods and applications
|
|
WO2007149476A2
(en)
|
2006-06-19 |
2007-12-27 |
Trustees Of Columbia University In The City Of New York |
Assays for non-apoptotic cell death and uses thereof
|
|
US20080003225A1
(en)
|
2006-06-29 |
2008-01-03 |
Henri Vie |
Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors
|
|
WO2008008719A2
(en)
|
2006-07-10 |
2008-01-17 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the myc gene
|
|
EP1878440A1
(en)
|
2006-07-13 |
2008-01-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds
|
|
CN101516365A
(zh)
|
2006-07-26 |
2009-08-26 |
诺瓦提斯公司 |
十一异戊二烯基焦磷酸酯合酶的抑制剂
|
|
US20080199961A1
(en)
|
2006-08-25 |
2008-08-21 |
Avi Biopharma, Inc. |
ANTISENSE COMPOSITION AND METHOD FOR INHIBITION OF miRNA BIOGENESIS
|
|
WO2008100292A2
(en)
|
2006-10-16 |
2008-08-21 |
Genelux Corporation |
Modified vaccinia virus strains for use in diagnostic and therapeutic methods
|
|
ES2639568T3
(es)
|
2007-01-23 |
2017-10-27 |
Janssen Pharmaceutica Nv |
Método para diseñar un régimen farmacológico para pacientes infectados con el VIH
|
|
AU2008240266A1
(en)
|
2007-04-12 |
2008-10-23 |
The Board Of Trustees Of The University Of Illinois |
Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
|
|
US20080293142A1
(en)
|
2007-04-19 |
2008-11-27 |
The Board Of Regents For Oklahoma State University |
Multiple shRNA Expression Vectors and Methods of Construction
|
|
EP2008656A1
(en)
|
2007-06-28 |
2008-12-31 |
Bergen Teknologioverforing AS |
Compositions for the treatment of hyperphenylalaninemia
|
|
US20110177155A1
(en)
|
2007-08-21 |
2011-07-21 |
Immune Disease Institute, Inc. |
Methods of delivery of agents to leukocytes and endothelial cells
|
|
US20110008417A1
(en)
|
2008-01-16 |
2011-01-13 |
Opal Therapeutics Pty Ltd |
Immunomodulating compositions and uses therefor
|
|
GB0802754D0
(en)
|
2008-02-14 |
2008-03-26 |
Inst Superiore Di Sanito |
Antisense RNA targetting CXCR4
|
|
EP2090659A1
(en)
|
2008-02-14 |
2009-08-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Infectious particle, process for its preparation and use thereof
|
|
CA2719938A1
(en)
|
2008-03-28 |
2009-10-01 |
Virxsys Corporation |
Lentivirus-based immunogenic vectors
|
|
GB0810209D0
(en)
|
2008-06-04 |
2008-07-09 |
Cambridge Entpr Ltd |
Pluripotency associated epigenetic factor
|
|
US8629334B2
(en)
|
2008-07-16 |
2014-01-14 |
University Of Florida Research Foundation, Inc. |
Viral-based transient-expression vector system for trees
|
|
US20110207226A1
(en)
|
2008-08-20 |
2011-08-25 |
Virxsys Corporation |
Non-integrating lenti/adeno-associated virus hybrid vector system
|
|
EP2342321B1
(en)
|
2008-09-17 |
2018-04-11 |
Isogenis, Inc. |
Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
|
|
WO2010045659A1
(en)
|
2008-10-17 |
2010-04-22 |
American Gene Technologies International Inc. |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
|
WO2010051521A1
(en)
|
2008-10-31 |
2010-05-06 |
Lentigen Corporation |
Cell therapy product for the treatment of hiv infection
|
|
CN102753193A
(zh)
|
2008-10-31 |
2012-10-24 |
比奥根艾迪克Ma公司 |
Light靶向分子及其用途
|
|
JP2012508591A
(ja)
|
2008-11-14 |
2012-04-12 |
ライフ テクノロジーズ コーポレーション |
細胞を操作するための組成物および方法
|
|
EP2191834A1
(en)
|
2008-11-26 |
2010-06-02 |
Centre National De La Recherche Scientifique (Cnrs) |
Compositions and methods for treating retrovirus infections
|
|
WO2010117974A2
(en)
*
|
2009-04-09 |
2010-10-14 |
Stemcyte Inc. |
Hiv-resistant stem cells and uses thereof
|
|
WO2010119039A1
(en)
|
2009-04-13 |
2010-10-21 |
Apceth Gmbh & Co. Kg |
Engineered mesenchymal stem cells and method of using same to treat tumors
|
|
US8728458B2
(en)
|
2009-04-30 |
2014-05-20 |
The Regents Of The University Of California |
Combination anti-HIV vectors, targeting vectors, and methods of use
|
|
CA2767972A1
(en)
*
|
2009-07-15 |
2011-01-20 |
Calimmune Inc. |
Dual vector for inhibition of human immunodeficiency virus
|
|
US20120135032A1
(en)
|
2009-10-08 |
2012-05-31 |
Bavarian Nordic A/S |
Generation of a broad t-cell response in humans against hiv
|
|
WO2011066578A1
(en)
|
2009-11-30 |
2011-06-03 |
American Gene Technologies International Inc. |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules to treat liver cancer
|
|
CN101805750B
(zh)
|
2009-12-29 |
2011-11-30 |
浙江大学 |
法呢基焦磷酸合成酶rna干扰重组慢病毒载体构建及用途
|
|
EP2536838A4
(en)
*
|
2010-02-18 |
2013-08-21 |
Univ Emory |
VECTOR FOR THE EXPRESSION OF HIV ANTIGENES AND GM-CSF AND CORRESPONDING METHODS FOR GENERATING IMMUNE RESPONSE
|
|
WO2011119942A1
(en)
|
2010-03-25 |
2011-09-29 |
Vistagen Therapeutics, Inc. |
Induction of ips cells using transient episomal vectors
|
|
WO2011133687A2
(en)
|
2010-04-20 |
2011-10-27 |
President And Fellows Of Harvard College |
Methods and compositions for inhibition of beta2-adrenergic receptor degradation
|
|
EP3502254B1
(en)
|
2010-04-23 |
2024-11-06 |
Cold Spring Harbor Laboratory |
Novel structurally designed shrnas
|
|
WO2011148194A1
(en)
|
2010-05-28 |
2011-12-01 |
Oxford Biomedica (Uk) Ltd |
Delivery of lentiviral vectors to the brain
|
|
US9670459B2
(en)
|
2010-08-10 |
2017-06-06 |
Takara Bio Inc. |
Production method for cell populations
|
|
WO2012048303A2
(en)
|
2010-10-07 |
2012-04-12 |
Columbia University |
METHOD FOR TREATING CANCER HARBORING A p53 MUTATION
|
|
WO2012061075A2
(en)
*
|
2010-10-25 |
2012-05-10 |
The Regents Of The University Of California |
Hiv resistant and functional hematopoietic stem/progenitor cells and macrophages from induced pluripotent stem cells
|
|
WO2012115980A1
(en)
|
2011-02-22 |
2012-08-30 |
California Institute Of Technology |
Delivery of proteins using adeno-associated virus (aav) vectors
|
|
US9492529B2
(en)
|
2011-04-13 |
2016-11-15 |
Immunicum Ab |
Method for priming of T cells
|
|
EP3318634A1
(en)
|
2011-04-21 |
2018-05-09 |
University of Massachusetts |
Raav-based compositions and methods for treating diseases involving dominant-negative or gain of function mutations
|
|
CA2856137A1
(en)
|
2011-11-22 |
2013-05-30 |
The Children's Hospital Of Philadelphia |
Virus vectors for highly efficient transgene delivery
|
|
US9745631B2
(en)
|
2011-12-20 |
2017-08-29 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
|
EP2812012A1
(en)
|
2012-02-07 |
2014-12-17 |
Global Bio Therapeutics USA, Inc. |
Compartmentalized method of nucleic acid delivery and compositions and uses thereof
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
EP2858667A1
(en)
|
2012-06-06 |
2015-04-15 |
Bionor Immuno AS |
Hiv vaccine
|
|
JP2015524264A
(ja)
|
2012-07-17 |
2015-08-24 |
ユニベルシテ ドゥ ジュネーブ |
遺伝子発現の下方制御のための核酸
|
|
WO2014052855A1
(en)
|
2012-09-27 |
2014-04-03 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
|
JP6391582B2
(ja)
|
2012-11-13 |
2018-09-19 |
コディアック バイオサイエンシズ インコーポレイテッド |
治療剤の送達方法
|
|
JP2016500254A
(ja)
|
2012-12-05 |
2016-01-12 |
サンガモ バイオサイエンシーズ， インコーポレイテッド |
代謝疾患の調節のための方法および組成物
|
|
US9642921B2
(en)
|
2012-12-20 |
2017-05-09 |
Tocagen Inc. |
Cancer combination therapy and recombinant vectors
|
|
WO2014117050A2
(en)
|
2013-01-26 |
2014-07-31 |
Mirimus, Inc. |
Modified mirna as a scaffold for shrna
|
|
CN103184224A
(zh)
*
|
2013-04-03 |
2013-07-03 |
衡阳师范学院 |
一种抗艾滋病病毒感染的三联miRNA及构建方法
|
|
US9719106B2
(en)
|
2013-04-29 |
2017-08-01 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
|
|
EP2999797B1
(en)
|
2013-05-21 |
2018-07-04 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Isoforms of gata6 and nkx2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy
|
|
WO2015017755A1
(en)
|
2013-08-02 |
2015-02-05 |
The Regents Of The University Of California |
Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors
|
|
WO2015042308A2
(en)
*
|
2013-09-18 |
2015-03-26 |
City Of Hope |
Rna-based hiv inhibitors
|
|
MX2016005239A
(es)
|
2013-10-22 |
2016-08-12 |
Shire Human Genetic Therapies |
Tratamiento con acido ribonucleico mensajero para la fenilcetonuria.
|
|
CN111218447B
(zh)
|
2013-11-07 |
2024-10-11 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
EP2878674A1
(en)
|
2013-11-28 |
2015-06-03 |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) |
Stable episomes based on non-integrative lentiviral vectors
|
|
GB201322091D0
(en)
|
2013-12-13 |
2014-01-29 |
Cambridge Entpr Ltd |
Modified serpins for the treatment of bleeding disorders
|
|
CA2946312A1
(en)
|
2014-04-23 |
2015-10-29 |
Juno Therapeutics, Inc. |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
|
EP3851537B1
(en)
|
2014-04-25 |
2023-12-27 |
Genethon |
Treatment of hyperbilirubinemia
|
|
MX382565B
(es)
|
2014-04-25 |
2025-03-13 |
2Seventy Bio Inc |
Receptores de antigenos quimericos del promotor mnd.
|
|
US20160060707A1
(en)
|
2014-08-29 |
2016-03-03 |
Immunomedics, Inc. |
Identification of Cancer Genes by In-Vivo Fusion of Human Cancer Cells and Animal Cells
|
|
DK3197472T3
(da)
|
2014-09-22 |
2021-10-18 |
Tanea Medical Ab |
Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri
|
|
MA40783A
(fr)
|
2014-10-03 |
2017-08-08 |
Los Alamos Nat Security Llc |
Vaccins contre le vih comprenant un ou plusieurs antigènes episensus de population
|
|
CA2964173A1
(en)
|
2014-10-10 |
2016-04-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods to eliminate cancer stem cells by targeting cd47
|
|
WO2016061232A2
(en)
|
2014-10-14 |
2016-04-21 |
Texas Tech University System |
Multiplexed shrnas and uses thereof
|
|
WO2016069518A2
(en)
|
2014-10-27 |
2016-05-06 |
International Aids Vaccine Initiative |
Genetically stable replication competent sendai virus vector(s) containing and expressing optimized hiv genes
|
|
WO2016069716A1
(en)
|
2014-10-30 |
2016-05-06 |
The Scripps Research Institute |
Compositions and methods comprising tyrosyl-trna synthetases and resveratrol compounds
|
|
CN108026543A
(zh)
|
2015-05-18 |
2018-05-11 |
卡琳缪恩股份有限公司 |
用于hiv的治疗的基因疗法及其用途
|
|
GB201509202D0
(en)
|
2015-05-28 |
2015-07-15 |
Ge Healthcare Bio Sciences Ab |
Semi-static cell culture
|
|
EP3307894A4
(en)
|
2015-06-10 |
2019-01-16 |
American Gene Technologies International, Inc. |
SYSTEM AND METHOD FOR NONINTEGRAL VIRAL OUTPUT AND METHOD FOR USE THEREOF
|
|
US11980663B2
(en)
|
2015-07-08 |
2024-05-14 |
American Gene Technologies International Inc. |
HIV pre-immunization and immunotherapy
|
|
CA2994192C
(en)
|
2015-08-13 |
2020-06-16 |
Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. |
Induced extended pluripotent stem cells, methods of making and using
|
|
CN105112370B
(zh)
|
2015-08-25 |
2019-02-05 |
杭州优善生物科技有限公司 |
一种体外刺激外周血γδT细胞高效增殖的方法及其应用
|
|
CN108779161A
(zh)
|
2015-09-22 |
2018-11-09 |
宾夕法尼亚大学董事会 |
重定向t细胞以治疗hiv感染的方法
|
|
WO2017068077A1
(en)
|
2015-10-20 |
2017-04-27 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and products for genetic engineering
|
|
WO2017100551A1
(en)
|
2015-12-09 |
2017-06-15 |
Alexion Pharmaceuticals, Inc. |
HETEROLOGOUS UTR SEQUENCES FOR ENHANCED mRNA EXPRESSION
|
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
|
IL279520B2
(en)
|
2016-01-15 |
2023-03-01 |
American Gene Tech Int Inc |
Methods and preparations for the activation of gamma-delta t cells
|
|
WO2017139065A1
(en)
|
2016-02-08 |
2017-08-17 |
American Gene Technologies International Inc. |
Hiv vaccination and immunotherapy
|
|
EP3426777B1
(en)
|
2016-03-09 |
2022-02-16 |
American Gene Technologies International Inc. |
Combination vectors and methods for treating cancer
|
|
WO2017173453A1
(en)
|
2016-04-01 |
2017-10-05 |
The Brigham And Women's Hospital, Inc. |
Stimuli-responsive nanoparticles for biomedical applications
|
|
WO2017213697A1
(en)
|
2016-06-08 |
2017-12-14 |
American Gene Technologies International Inc. |
Non-integrating viral delivery system and methods related thereto
|
|
EP3481418A4
(en)
|
2016-07-08 |
2020-03-11 |
American Gene Technologies International Inc. |
PRE-IMMUNIZATION AND IMMUNOTHERAPY OF HIV
|
|
EP3487507A4
(en)
|
2016-07-21 |
2020-04-08 |
American Gene Technologies International, Inc. |
VIRAL VECTORS FOR THE TREATMENT OF PARKINSON'S DISEASE
|
|
JP6923215B2
(ja)
|
2016-08-03 |
2021-08-18 |
国立大学法人 鹿児島大学 |
抗ｈｔｌｖ−１剤、ｈｔｌｖ−１関連脊髄症（ｈａｍ／ｔｓｐ）治療薬
|
|
CN110325199A
(zh)
|
2016-12-30 |
2019-10-11 |
宾夕法尼亚州立大学托管会 |
用于治疗苯丙酮尿症的基因疗法
|
|
AU2018205388A1
(en)
|
2017-01-09 |
2019-07-18 |
American Gene Technologies International Inc. |
HIV immunotherapy with no pre-immunization step
|
|
US12023385B2
(en)
|
2017-02-08 |
2024-07-02 |
Dana-Farber Cancer Institute, Inc. |
Tunable endogenous protein degradation with heterobifunctional compounds
|
|
EP3607072A4
(en)
|
2017-04-03 |
2021-01-06 |
American Gene Technologies International Inc. |
COMPOSITIONS AND METHODS OF TREATMENT OF PHENYLCETONURISM
|
|
KR20200018586A
(ko)
|
2017-06-16 |
2020-02-19 |
아메리칸 진 테크놀로지스 인터내셔널 인코포레이티드 |
인간 감마-델타 t-세포를 통한 종양 세포독성의 활성화를 위한 방법 및 조성물
|
|
KR20200057766A
(ko)
|
2017-10-02 |
2020-05-26 |
아메리칸 진 테크놀로지스 인터내셔널 인코포레이티드 |
페닐케톤뇨증을 치료하기 위한 프로모터 및 인핸서 조합을 포함하는 벡터
|
|
KR20200135852A
(ko)
|
2018-03-27 |
2020-12-03 |
아메리칸 진 테크놀로지스 인터내셔널 인코포레이티드 |
유전자 변형 림프구의 제조 방법
|
|
US11352646B2
(en)
|
2018-11-05 |
2022-06-07 |
American Gene Technologies International Inc. |
Vector system for expressing regulatory RNA
|
|
CA3137698A1
(en)
|
2019-05-31 |
2020-12-03 |
Tyler LAHUSEN |
Optimized phenylalanine hydroxylase expression
|